logo BDSP

Base documentaire

  1. Vitamin E prophylaxis to reduce retinopathy of prematurity : A reappraisal of published trials.

    Article - En anglais


    We conducted a meta-analysis of the published randomized clinical trials of vitamin E prophylaxis designed to reduce retinopathy of prematurity (ROP) to determine whether increased serum concentrations of vitamin E reduced the incidence of severe, threshold (Stage 3+) ROP in the very low birth weight (VLBW) infant subset.

    Study Design 

    Among the six trials considered eligible for analyses, the incidence for all stages of ROP and for Stage 3+ROP was computed for all randomly assigned infants (intention-to-treat analysis) and for those infants completing the trials.

    Odds ratios (ORs) and pooled estimates for event rate reductions (and the respective 95% confidence intervals [CIs]) were calculated for these outcome end points.


    There were 704 VLBW infants in the vitamin E prophylaxis groups and 714 in control groups ; 536 (76.1%) infants in the vitamin E and 551 (77.2%) in the control groups completed the trials.

    In all trials the mean serum vitamin E concentrations were within or above the physiologic range in the vitamin-treated groups and at or below the physiologic ranges in the control groups.

    The overall incidence of any stage ROP was similar between the groups : 39.8% in the vitamin E group and 43.5% in the control group.

    The overall incidence for Stage 3+ROP was lower in the vitamin E-treated groups than in the control group (2.4% in vitamin E vs 5.3% in control).

    The pooled OR for developing Stage 3+ROP with vitamin E prophylaxis was 0. (...)

    Mots-clés Pascal : Fibroplasie rétrolentale, Nouveau né, Homme, Prématurité, Traitement, Prévention, Chimiothérapie, alpha-Tocophérol, Complément alimentaire, Efficacité traitement, Exploration, Concentration, Sérum, Epidémiologie, Incidence, Essai clinique, Revue bibliographique, Prématuré, Oeil pathologie, Rétinopathie, Nouveau né pathologie

    Mots-clés Pascal anglais : Retrolental fibroplasia, Newborn, Human, Prematurity, Treatment, Prevention, Chemotherapy, alpha-Tocopherol, Food supplement, Treatment efficiency, Exploration, Concentration, Serum, Epidemiology, Incidence, Clinical trial, Bibliographic review, Premature, Eye disease, Retinopathy, Newborn diseases

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 98-0090819

    Code Inist : 002B26B. Création : 14/05/1998.